Skip to main content
Home
Member Login
Join Our Contact Registry
RDCRN logo

Header Social Media

  • Our Research
    • Diseases Studied
    • Research Studies
    • Clinical Sites
    • Research Publications
  • Patients and Families
    • Patient Advocacy Groups
    • Participate
    • Letters of Support
  • Researchers and Clinicians
    • Collaborate with Us
    • Funding Opportunities
    • Project Data
  • Early Stage Investigators
    • Funding Opportunities
    • Career Development Award
    • Advocacy Advancement Award
    • Community Award
    • Pilot Project Award
    • Scholar Program
  • News and Events
    • Latest News
  • About Us
    • Our Consortium
    • Committees
    • Meet Our Investigators
    • Meet Our Leadership & Administration Teams
    • Goals, Mission & Vision
    • Contact Us
An NIH-Funded Rare Diseases Clinical Research Network Consortium

Sitemap

A quick map of the Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) site.

About Us

  • Our Consortium
  • Committees
  • Meet Our Investigators
  • Meet Our Leadership & Administration Teams
  • Goals, Mission & Vision
  • Contact Us

Our Research

  • Diseases Studied
  • Research Studies
  • Clinical Sites
  • Research Publications

News and Events

  • Latest News

Patients and Families

  • Patient Advocacy Groups
  • Participate
  • Letters of Support

Researchers and Clinicians

  • Collaborate with Us
  • Funding Opportunities
  • Project Data

Early Stage Investigators

  • Funding Opportunities
  • Career Development Award
  • Advocacy Advancement Award
  • Community Award
  • Pilot Project Award
  • Scholar Program

Footer menu

  • Web Policies
  • Rare Diseases Clinical Research Network
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us
  • Sitemap

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDI). GLIA-CTN is funded under grant number U54NS115052 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the GLIA-CTN administrative coordinating center at Children’s Hospital of Philadelphia and does not necessarily represent the official views of the NIH.

social media